People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ZetaRx Biosciences, Inc. | — | Biotechnology | Seed | $2.8M | $88.8M | 2012 |
Cynthia Shumate at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Cynthia Shumate on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jack Kavanaugh | 1 | 6 |
| Werner F. Wolfen | 1 | 2 |
| D. Verne Sharma | 1 | 2 |
| David A. Dull | 1 | 2 |
| Robert Verne Snukal | 1 | 2 |
| Ken A. Mohler | 1 | 1 |
| Gordon M. Binder | 1 | 1 |
| Cynthia M. Shumate | 1 | 1 |
| Edmund M. Olivier | 1 | 1 |
| Cynthia Verne Shumate | 1 | 1 |
| Robert F. Snukal | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.